| | | | | | | | Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of September 18 |
|
|
|
| |
| | |
|
|
| | | | | Just a few weeks ago, the companies shared positive data testing the experimental drug in lung cancer. |
|
|
| Glenmark will divest 75% of its stake in its generic API business, GLS. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | This pharma manufacturer’s main facility supplies its sister sites with materials. However, receiving sites complained regularly about inventory errors due to inaccurate material weights, despite daily scale calibration that wasted time and effort. Additionally, the current equipment setup was large and hard to clean. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
